Tabernacki, T.; Wang, L.; Kaelber, D.C.; Xu, R.; Berger, N.A.
Non-Insulin Antidiabetic Agents and Lung Cancer Risk in Drug-Naive Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study. Cancers 2024, 16, 2377.
https://doi.org/10.3390/cancers16132377
AMA Style
Tabernacki T, Wang L, Kaelber DC, Xu R, Berger NA.
Non-Insulin Antidiabetic Agents and Lung Cancer Risk in Drug-Naive Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study. Cancers. 2024; 16(13):2377.
https://doi.org/10.3390/cancers16132377
Chicago/Turabian Style
Tabernacki, Tomasz, Lindsey Wang, David C. Kaelber, Rong Xu, and Nathan A. Berger.
2024. "Non-Insulin Antidiabetic Agents and Lung Cancer Risk in Drug-Naive Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study" Cancers 16, no. 13: 2377.
https://doi.org/10.3390/cancers16132377
APA Style
Tabernacki, T., Wang, L., Kaelber, D. C., Xu, R., & Berger, N. A.
(2024). Non-Insulin Antidiabetic Agents and Lung Cancer Risk in Drug-Naive Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study. Cancers, 16(13), 2377.
https://doi.org/10.3390/cancers16132377